Its overexpression in osteosarcoma cells reduces HAS2 transcript [125], while in oral squamous cell carcinoma, it induces HAS2 transcription and hypoxia-induced invasiveness [126]. This evidence concerns the gene HAS2 and oral cavity squamous cell carcinoma.